Uzbekistan reports 6.73 million patients treated under state health insurance since 2021

September 20, 2026 at 10:04 PM2 min

This digest was compiled by AI from multiple sources — links to the originals are below.

Uzbekistan's State Health Insurance Fund has treated over 6.73 million patients in regions with mandatory health insurance mechanisms between 2021 and 2026, allocating more than 26.8 trillion soums. In the first half of 2026 alone, over 2.363 million patients received care at a cost of 9.86 trillion soums. The Agency for Development of the Pharmaceutical Industry is participating in the CPHI Shenzhen-2026 exhibition in China to discuss localization, technology transfer, and joint ventures.

Key Facts

Between 2021 and 2026, over 6.73 million patients were treated in regions where state health insurance mechanisms were introduced, according to responsible agencies.
More than 26.8 trillion soums were allocated to strengthen the material and technical base and improve the quality of medical services in these regions.
In the first half of 2026, over 2.363 million patients received necessary medical care, with 9.86 trillion soums spent.
The Agency for Development of the Pharmaceutical Industry is participating in the CPHI Shenzhen-2026 international pharmaceutical exhibition in Shenzhen, China.
During the 'Health Marathon' in Namangan region, over 5,000 citizens underwent in-depth medical examinations and modern diagnostic tests.

State Health Insurance Results

Responsible agencies report that from 2021 to 2026, more than 6.73 million patients were treated in regions where state health insurance mechanisms were implemented. Over 26.8 trillion soums were directed to strengthening the material and technical base and improving the quality of medical services. In the first six months of 2026, over 2.363 million patients received necessary medical care, with 9.86 trillion soums spent for these purposes.

Pharmaceutical Cooperation with China

Employees of the Agency for Development of the Pharmaceutical Industry are participating in the CPHI Shenzhen-2026 international pharmaceutical exhibition in Shenzhen, China. Meetings are being held with pharmaceutical companies and manufacturers from China and other countries to discuss localization, technology transfer, joint ventures, new production projects, and research cooperation. Uzbekistan's investment opportunities in the pharmaceutical sector are being presented to international companies, with negotiations underway to bring promising projects to the practical stage.

Health Marathon in Namangan

A large-scale 'Health Marathon' aimed at preventing heart attacks and strokes, early detection of cardiovascular diseases, and reducing premature mortality was held in Namangan region. Doctors from the X-ray endovascular department of the National Medical Center provided qualified medical care on site and actively participated in early detection and treatment of cardiovascular pathologies. During the marathon, over 5,000 citizens across the region underwent in-depth medical examinations and modern diagnostic tests. In Toraqorgon district, more than 500 citizens had their health assessed, and 40 patients with serious cardiovascular changes were referred for stenting, while 20 patients were referred for high-tech surgery for aortic coarctation.